Editas Medicine (EDIT) Return on Capital Employed Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 68,255.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 2,665.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 31,429.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2,503.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -105.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 2,400.00 |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -5,720.00 |
| Jun 30, 2025 | -7,721.00 |
| Mar 31, 2025 | -6,750.00 |
| Dec 31, 2024 | -5,903.00 |
| Sep 30, 2024 | -3,561.00 |
| Jun 30, 2024 | -1,481.00 |
| Mar 31, 2024 | 642.00 |
| Dec 31, 2023 | 1,028.00 |
| Sep 30, 2023 | -516.00 |
| Jun 30, 2023 | -1,530.00 |
| Mar 31, 2023 | -2,188.00 |
| Dec 31, 2022 | -1,915.00 |
| Sep 30, 2022 | -803.00 |
| Jun 30, 2022 | -877.00 |
| Mar 31, 2022 | -678.00 |
| Dec 31, 2021 | -410.00 |
| Sep 30, 2021 | -1,275.00 |
| Jun 30, 2021 | 673.00 |
| Mar 31, 2021 | 1,361.00 |
| Dec 31, 2020 | 1,142.00 |
| Sep 30, 2020 | 2,402.00 |
| Jun 30, 2020 | 634.00 |
| Mar 31, 2020 | -567.00 |
| Dec 31, 2019 | -613.00 |
| Sep 30, 2019 | -1,165.00 |
| Jun 30, 2019 | -406.00 |
| Mar 31, 2019 | 54.00 |
| Sep 30, 2018 | 641.00 |
| Jun 30, 2018 | 196.00 |
| Mar 31, 2018 | 983.00 |
| Sep 30, 2017 | -734.00 |
| Jun 30, 2017 | -1,096.00 |
| Mar 31, 2017 | -1,659.00 |